CLSA Premium Ltd. (HK:6877) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
CLSA Premium Limited has announced the successful fulfillment of the resumption guidance set by the Stock Exchange, resulting in a notable turnaround for its Healthcare Business. The company’s diligent management has led to a significant revenue increase to HK$191.4 million and a net profit of HK$9.8 million in 2023, showcasing its potential for growth and marking a stark improvement from the previous year’s net loss.
For further insights into HK:6877 stock, check out TipRanks’ Stock Analysis page.